Jant Pharmacal
Jant Pharmacal is a US specialty distributor that markets Accutest® and Accustrip® point-of-care diagnostics and distributes clinical lab analyzers, reagents, and quality controls from major OEMs to physicians' offices, clinics, hospitals, and reference laboratories.
- Company typePrivate
- Founded1986
- HeadquartersEncino, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Jant Pharmacal does
Jant Pharmacal Corporation is a privately held US specialty medical device distributor founded in 1986 and headquartered in Encino, California. The company develops, markets, and distributes point-of-care diagnostics and clinical laboratory analyzers, reagents, and quality control products to physicians' offices, clinics, hospitals, and reference laboratories across the United States. Its portfolio is organized into three divisions: Point-of-Care Diagnostics (CLIA-waived rapid tests marketed under its registered Accutest® and Accustrip® brands for cardiac, infectious disease, drugs of abuse, pregnancy, hypothyroid, colorectal, and urinalysis testing); Core Laboratory (CLIA-moderate and high-complexity analyzers and reagents from OEM partners including Beckman Coulter, Tosoh, HORIBA, Mindray, and Medonic, plus quality control products from Thermo Scientific MAS, Randox, and Quantimetrix, and Bolt/ThunderBolt chemiluminescent immunoassay platforms); and Molecular Testing (Research Use Only NGS, extraction, real-time PCR, and RUO/EUA COVID panels). The company also offers laboratory consultation services spanning financial feasibility assessment, turn-key lab setup, CLIA regulatory compliance, LCMS method development, and LIS integration.
Jant Pharmacal generates revenue primarily through hardware and consumable sales of distributed diagnostic instruments and reagents, complemented by recurring reagent/quality-control consumable pull-through (razor/blade economics on placed analyzers), OTC/home testing product sales (Flowflex, Healgen, OraQuick), and fee-based laboratory consulting. Go-to-market is direct: a toll-free sales line (800-676-5565), a transactional website with product catalogs and quote/contact forms, and email newsletters. The GTM motion targets two distinct buyer types: bottom-of-funnel direct sales to physicians' offices and clinics (for POC testing), and field/enterprise sales to hospital and reference labs (for full analyzer/reagent solutions), supported by ROI assessments and turn-key setup services that reduce buyer friction.
The company's core technology is not proprietary instrument development but rather curation and channel integration of CLIA-compliant diagnostic workflows: integrating CLIA-waived rapid tests with CLIA-moderate/high-complexity analyzers, reagents, QC controls, and bidirectional LIS interfaces (notably on the Bolt chemiluminescent analyzer). Brand equity in Accutest® and Accustrip® (registered trademarks since 1986) and ~40 years of distribution relationships with major IVD OEMs constitute the primary commercial assets. There is no disclosed external institutional investment, no parent company, no subsidiaries, and no public M&A activity in the source material.
Jant Pharmacal firmographics
Firmographics- Name
- Jant Pharmacal
- Legal name
- Jant Pharmacal Corporation
- Website
- https://jantdx.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Jant Pharmacal is a US specialty distributor that markets Accutest® and Accustrip® point-of-care diagnostics and distributes clinical lab analyzers, reagents, and quality controls from major OEMs to physicians' offices, clinics, hospitals, and reference laboratories.
- Ownership category
- akta.pro rank
Jant Pharmacal industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI)
Keywords
Where Jant Pharmacal is headquartered
LocationHeadquarters
- HQ city
- Encino
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Jant Pharmacal business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Point-of-Care Diagnostic Products: Sale of CLIA-waived rapid tests under Accutest® and Accustrip® brands for cardiac testing, colorectal cancer, drugs of abuse, hypothyroidism, infectious diseases, pregnancy & fertility, and urinalysis.
- Laboratory Analyzers and Reagents: Sale and distribution of clinical chemistry, hematology, immunoassay, toxicology, and urinalysis systems and reagents from OEM partners including Beckman Coulter, Mindray, and HORIBA.
- Quality Control Products: Distribution of QC/control products from Randox, Quantimetrix, and Thermo Scientific MAS for laboratory quality assurance.
- Laboratory Consultation Services: Services including Financial Feasibility Assessment, Turn-Key Laboratory Setup, CLIA Regulatory Consultation, LCMS Method Development, and Laboratory Information System Integration.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Jant Pharmacal product offering
Product offeringCore offering
Jant Pharmacal develops, markets, and distributes in vitro diagnostic products organized across three divisions: Point-of-Care Diagnostics (CLIA-waived rapid tests marketed under Accutest® and Accustrip® brands for cardiac, infectious disease, urinalysis, drugs of abuse, pregnancy, and colorectal cancer screening); Core Laboratory Analyzers and Reagents (clinical chemistry, immunoassay, hematology, toxicology, LCMS systems and reagents from OEM partners such as Beckman Coulter, Mindray, HORIBA, Tosoh, AB Sciex, Agilent, and Shimadzu); and Molecular Testing (RUO/EUA next-generation sequencing, extraction, real-time PCR). The company also provides laboratory consultation services including LCMS method development, CLIA regulatory compliance, financial feasibility assessments, and turn-key laboratory setup.
Product overview
Jant Pharmacal Corporation, founded in 1986 and headquartered in Encino, California, offers a comprehensive portfolio of medical diagnostics products organized across three main divisions: Point-of-Care Diagnostics (under Accutest® and Accustrip® brands), Core Laboratory Analyzers and Reagents (CLIA Moderate and High Complexity), and Molecular Testing (Research Use Only). The Point-of-Care division provides CLIA-waived rapid tests for cardiac markers (RAMP 200, RAMP Cardiovascular Markers), infectious diseases (HIV, RSV, H. pylori, COVID-19/Flu), urinalysis (Accutest UriScreen, Accutest Urine Reagent Strips, Accustrip URS Reader), drugs of abuse screening, pregnancy testing, and colorectal cancer screening. The Core Laboratory division encompasses clinical chemistry analyzers (Indiko Plus, Mindray BA-800M/BS-480, Beckman Coulter AU series, refurbished Olympus AU systems), immunoassay systems (Tosoh AIA-360/900/2000, FREND by NanoEntek, Bolt ELISA/CLIA, ThunderBolt), hematology analyzers (HORIBA ABX Micros/Pentra series, Medonic M-Series), and comprehensive quality controls (Randox, Quantimetrix, Thermo Scientific MAS). The Molecular Testing division supplies next-generation sequencing products, automated and manual extraction systems, real-time PCR instruments and panels, and specialized panels for respiratory, gastrointestinal, antibiotic resistance, pharmacogenomics, and COVID/EUA testing. Jant Pharmacal also provides laboratory consulting services including LCMS method development, CLIA regulatory compliance, financial feasibility assessments, and turn-key laboratory setup.
Differentiator
Problem solved
Functional benefit
Brands
- Accutest®: Registered trademark for point-of-care rapid test products
- Accustrip®
Products and services
- Accutest UriScreen Rapid point-of-care diagnostic test for urinary tract infection screening for use in physicians' offices, clinics, and laboratories.
- Accutest Urine Reagent Strips Semi-quantitative dipstick test strips for rapid urinalysis testing under the Accutest® brand.
- Accustrip URS Reader & Strips
- RAMP 200 Response Bio Cardiac Diagnostic System CLIA-moderate complexity cardiac diagnostic system for rapid NT-proBNP testing at point-of-care settings.
- RAMP Cardiovascular Markers
- RAMP RSV Test
- Accutest H. pylori Urease Test Rapid point-of-care test for detection of Helicobacter pylori infection using urease methodology.
- Flowflex RSV + Flu A/B + COVID Home Test 4-in-1 home test for simultaneous detection of RSV, Influenza A/B, and COVID-19 from nasal swab samples.
- Healgen Rapid Check COVID-19/Flu A&B Antigen OTC Test Over-the-counter rapid antigen test for simultaneous detection of COVID-19 and Influenza A and B.
- OraQuick HIV Self-Test
- RSV Antigen Rapid Test Kit Rapid antigen test for RSV detection.
- Indiko Plus Clinical & Specialty Chemistry Analyzer
- Mindray BA-800M Chemistry and Toxicology Analyzer
- Mindray BS-480 Chemistry and Toxicology Analyzer
- Beckman Coulter AU Reagents
- Refurbished AU480 Chemistry/Toxicology Analyzer
- Refurbished AU640 Chemistry/Toxicology Analyzer
- Refurbished AU680 Chemistry/Toxicology Analyzer
- Refurbished AU5800 Chemistry/Toxicology Analyzer
- Immunalysis ImmTox 270 Benchtop Analyzer
- Tosoh AIA-360 Automated Immunoassay Analyzer
- Tosoh AIA-900 Automated Immunoassay Analyzer
- Tosoh AIA-2000 Automated Immunoassay Analyzer
- Tosoh AIA Reagents (Immunology)
- FREND System by NanoEntek
- NanoEntek FREND Reagents (Immunology)
- The Bolt ELISA and CLIA Assay Chemiluminescent Analyzer Compact one-plate ELISA and CLIA processor with modular design combining pipette, washer, incubator, shaker, and reader for automated immunoassay processing; software integrates with most Laboratory Information Systems.
- ThunderBolt ELISA and Chemiluminescent Analyzer High-performance ELISA and chemiluminescence analyzer for clinical and research immunoassay applications.
- Horiba ABX Micros ESV 60 Vet Hematology Analyzer
- Horiba ABX Micros 60 Hematology Analyzer
- Horiba ABX Micros ES60 Hematology Analyzer
- Horiba ABX Pentra 60 C+ Hematology Analyzer
- Horiba ABX Pentra XL 80 Hematology Analyzer
- HORIBA Reagents (Chemistry & Hematology)
- Medonic M-Series Hematology Analyzer (Autoloader Sampling)
- Medonic M-Series Hematology System (Closed Vial)
- Medonic M-Series Hematology System (Open Vial)
- Randox Controls
- Quantimetrix Controls
- Thermo Scientific MAS Quality Controls
- Thermo Scientific MAS UA Controls Bi-level liquid ready-to-use urinalysis controls with improved room temperature storage, covering 10 dipstick tests plus Microalbumin, Creatinine and hCG.
- Thermo Scientific MAS Serum Tox Control Set Control set for monitoring semi-quantitative measurement of Benzodiazepine, Barbiturates, and Tricyclic Antidepressants in human serum, plasma, and urine.
- Next-Generation Sequencing Solutions
- Automated and Manual Extraction Systems
- Real-Time PCR Instruments and Panels
- RUO/EUA COVID Panels for RT-PCR
- LCMS Method Transfer & Validation
- System Specific Method Development and Installation
- CLIA Regulatory and Compliance Consultation
- Financial Feasibility Assessment
- Turn-Key Laboratory Setup
- Laboratory Information System Selection and Integration
Companies that use Jant Pharmacal
Customer profileSegments3 records
Ideal customer profiles3 records
Jant Pharmacal technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Jant Pharmacal partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core.
- Beckman CoultercoreDistribution partner for Beckman Coulter AU reagents (bar-coded and pour over formats) and Beckman Coulter AU series analyzers including AU400, AU480, AU640, AU680, and AU5800. Jant Pharmacal offers both new and refurbished Beckman Coulter analyzers along with the complete test menu reagents.
- AB SciexcoreSupplier of Liquid Chromatography/Mass Spectrometry (LCMS) analyzers for toxicology laboratories. Jant Pharmacal offers both new and refurbished AB Sciex LCMS systems along with method validation assistance and related standards/reagents.
- AgilentcoreSupplier of LCMS analyzers for toxicology labs. Jant Pharmacal offers Agilent LCMS systems (new or refurbished) with method validation support.
- ShimadzucoreSupplier of LCMS analyzers for toxicology laboratories. Jant Pharmacal offers Shimadzu LCMS systems with method development and installation services.
- Gold Standard Diagnostics (Eurofins Technologies)coreManufacturer of the BOLT ELISA and CLIA Assay Chemiluminescent Analyzer, a one-plate ELISA+CLIA processor. Eurofins Technologies' strategic partner Gold Standard Diagnostics manufactures this instrument which Jant Pharmacal distributes.
- Thermo Scientific MAScoreDistribution of Thermo Scientific MAS quality controls including UA Controls, Serum Tox Control Set, and related control products for laboratory quality assurance.
- TosohcoreDistribution of Tosoh AIA immunoassay analyzers (AIA-360, AIA-900, AIA-2000) and reagents for automated immunoassay testing in laboratory settings.
- NanoEntekcoreDistribution of NanoEntek FREND System and reagents for immunoassay testing applications.
- HORIBAcoreDistribution of HORIBA ABX hematology analyzers including Micros ESV 60, Micros 60, Micros ES60, Pentra 60 C+, and Pentra XL 80, along with HORIBA reagents for chemistry and hematology testing.
- MindraycoreDistribution of Mindray chemistry and toxicology analyzers including BA-800M and BS-480, along with compatible reagents.
- ImmunalysiscoreDistribution of Immunalysis ImmTox 270 benchtop analyzer for toxicology testing applications.
- CDS (Clinical Diagnostic Systems)coreManufacturer of Medonic M-Series Hematology Analyzers (Open Vial, Closed Vial, and Autoloader sampling systems) distributed by Jant Pharmacal.
Scale indicators2 records
Recent moves6 records
Expansion highlights3 records
Jant Pharmacal competitors and assessment
Company assessmentDirect peers
- BTNX: Canadian rapid lateral-flow manufacturer (Rapid Response branded tests for drugs of abuse, infectious disease, cardiac markers); directly comparable to Accutest-branded POC tests with overlapping product menu and customer segments.
- Sekisui Diagnostics: Manufacturer of OSOM rapid immunoassay tests for physician office labs and clinics, plus clinical chemistry systems; competes head-to-head with Jant's Accutest line and CLIA-waived POC portfolio.
- Chembio Diagnostics: Smaller-scale US-listed rapid diagnostics developer focused on lateral-flow POCT (HIV, syphilis, COVID/Flu). Comparable in size and product focus to Jant's branded rapid-test business and faces the same competitive dynamics from scaled POCT players.
- Princeton BioMeditech: US rapid diagnostics manufacturer whose BioSign rapid tests compete directly with Accutest POC cards; sized similarly to Jant and operating in the same physician-office distribution model.
- QuidelOrtho: US-based rapid diagnostics leader (QuickVue, Sofia, Triage) serving physician offices, urgent care and laboratories with lateral-flow and immunoassay POCT — directly comparable to Jant's Accutest/Accustrip franchise and broader POC distribution business.
Emerging players
- SD Biosensor: Korean rapid diagnostics manufacturer growing its Standard Q/BIOCREDIT lateral-flow portfolio in the US through OTC retail and professional channels; overlaps with Jant's Accutest, Healgen, and Flowflex rapid-test franchises.
Broad incumbents
- Henry Schein: Major US distributor of medical, dental, and laboratory products to physician offices and clinics; competes for the same point-of-care and consumables wallet as Jant across the physician-office lab segment.
- McKesson Medical-Surgical: Largest US distributor of medical-surgical supplies to physician offices and laboratories; comparable wholesale/distribution model in the same physician-office channel that Jant Pharmacal serves.
- Beckman Coulter: Core OEM partner for the AU clinical chemistry series and DxH hematology analyzers Jant distributes; competes directly with Jant's bundled lab solutions via its own direct sales and service network in US hospitals and reference labs.
- Abbott Point of Care: i-STAT and Alinity systems dominate the CLIA-waived cardiac and chemistry POCT market served by Jant; a broad incumbent whose scale and existing hospital contracts set the pricing and competitive baseline against Jant's POC offering.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
Jant Pharmacal social profiles
Digital presenceJant Pharmacal financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jant Pharmacal leadership team
Management profileNumber of profiles
Jant Pharmacal funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jant Pharmacal M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jant Pharmacal
What does Jant Pharmacal do?
Jant Pharmacal develops, markets, and distributes in vitro diagnostic products organized across three divisions: Point-of-Care Diagnostics (CLIA-waived rapid tests marketed under Accutest® and Accustrip® brands for cardiac, infectious disease, urinalysis, drugs of abuse, pregnancy, and colorectal cancer screening); Core Laboratory Analyzers and Reagents (clinical chemistry, immunoassay, hematology, toxicology, LCMS systems and reagents from OEM partners such as Beckman Coulter, Mindray, HORIBA, Tosoh, AB Sciex, Agilent, and Shimadzu); and Molecular Testing (RUO/EUA next-generation sequencing, extraction, real-time PCR). The company also provides laboratory consultation services including LCMS method development, CLIA regulatory compliance, financial feasibility assessments, and turn-key laboratory setup.
Is Jant Pharmacal a public or private company?
Jant Pharmacal is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Jant Pharmacal founded?
Jant Pharmacal was founded in 1986. It employs 11 to 50 people.
Where is Jant Pharmacal based?
Jant Pharmacal is headquartered in Encino, United States, in the North America region.
How does Jant Pharmacal make money?
Four revenue lines are on record. Point-of-Care Diagnostic Products are the primary driver. The others are laboratory Analyzers and Reagents, quality Control Products and laboratory Consultation Services.
Who are Jant Pharmacal's main competitors?
Direct peers on record are BTNX, Sekisui Diagnostics, Chembio Diagnostics, Princeton BioMeditech and QuidelOrtho. SD Biosensor is listed as an emerging player. Broad incumbents are Henry Schein, McKesson Medical-Surgical, Beckman Coulter and Abbott Point of Care.
Does Jant Pharmacal have an API?
No public API is recorded for Jant Pharmacal.
What industry is Jant Pharmacal in?
Jant Pharmacal's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAOAI, Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges). Its NAICS code is 325413 and its SIC code is 2835.